E1	Condition:T1 Name:T2
E3	Procedure:T3 Name:T4 Temporality:E2 Temporality2:E22
E5	Procedure:T5 Name:T6
E7	Procedure:T7 Name:T8 Temporality:E22 Temporality2:E2
E9	Condition:T9 Name:T10
E11	Procedure:T11 Name:T12 Temporality:E12 Temporality2:E21
E13	Condition:T13 Name:T14
E17	Condition:T17 Name:T18
E18	Eq-Comparison:T24 Operator:T19 Value:T33 Value2:T45 Per:T46
E2	Eq-Comparison:T26 Temporal-Recency:T25
E4	Condition:T27 Name:T28
E6	Drug:T29 Name:T30 Temporality:E24
E8	Modifier:T31 Modifies:E6
E10	Modifier:T32 Modifies:E9
E14	Condition:T15 Name:T16
E15	Observation:T34 Name:T35 Numeric-Filter:E18
E20	Procedure:T37 Name:T38
E21	Eq-Comparison:T39 Operator:T20 Temporal-Unit:T21 Value:T23
E22	Eq-Comparison:T40 Temporal-Period:T41
E24	Eq-Comparison:T43 Temporal-Period:T44
E12	Eq-Comparison:T47 Temporal-Period:T48
T1	Condition 426 455	coagulation factor deficiency
T2	Condition-Name 426 455	coagulation factor deficiency
T3	Procedure 56 86	cardiopulmonary bypass surgery
T4	Procedure-Name 56 86	cardiopulmonary bypass surgery
T5	Procedure 196 218	cardiopulmonary bypass
T6	Procedure-Name 196 218	cardiopulmonary bypass
T7	Procedure 130 156	tissue mitral valve repair
T8	Procedure-Name 130 156	tissue mitral valve repair
T9	Condition 256 271	Aortic Stenosis
T10	Condition-Name 256 271	Aortic Stenosis
T11	Procedure 510 525	heparin therapy
T12	Procedure-Name 510 525	heparin therapy
T13	Condition 300 332	acquired von Willebrand Syndrome
T14	Condition-Name 300 332	acquired von Willebrand Syndrome
T17	Condition 459 485	platelet function disorder
T18	Condition-Name 459 485	platelet function disorder
T19	Eq-Operator 388 389	<
T20	Eq-Operator 539 545	within
T21	Eq-Temporal-Unit 553 557	days
T23	Eq-Value 551 552	7
T24	Eq-Comparison 388 398	<100x109/L
T25	Eq-Temporal-Recency 45 55	first time
T26	Eq-Comparison 45 55	first time
T27	Condition 105 126	atrial septal defects
T28	Condition-Name 105 126	atrial septal defects
T29	Drug 184 191	Heparin
T30	Drug-Name 184 191	Heparin
T31	Modifier 172 183	intravenous
T32	Modifier 244 255	Concomitant
T15	Condition 334 338	aVWS
T16	Condition-Name 334 338	aVWS
T34	Observation 370 384	platelet count
T35	Observation-Name 370 384	platelet count
T37	Procedure 535 538	CPB
T38	Procedure-Name 535 538	CPB
T39	Eq-Comparison 539 557	within last 7 days
T40	Eq-Comparison 34 44	undergoing
T41	Eq-Temporal-Period 34 44	undergoing
T43	Eq-Comparison 162 171	Receiving
T44	Eq-Temporal-Period 162 171	Receiving
T33	Eq-Value 389 392	100
T45	Eq-Value 393 396	109
T46	Eq-Unit 397 398	L
T47	Eq-Comparison 500 509	receiving
T48	Eq-Temporal-Period 500 509	receiving
A1	Eq-Operator-Value T19 LT
A2	Eq-Operator-Value T20 LTEQ
A3	Eq-Temporal-Unit-Value T21 day
A4	Eq-Temporal-Recency-Value T25 first-time
A5	Observation-Type-Value E15 lab
A7	Eq-Temporal-Period-Value T41 present
A8	Eq-Temporal-Period-Value T44 present
A9	Eq-Temporal-Period-Value T48 present
R1	Abbrev-Of Arg1:E14 Arg2:E13
R2	Treatment-For Arg1:E3 Arg2:E4
R3	Using Arg1:E5 Arg2:E6
R4	Caused-By Arg1:E9 Arg2:E13
R5	Or Arg1:E1 Arg2:E17
R6	Before Arg1:E11 Arg2:E20
R7	Or Arg1:E3 Arg2:E7
